Cancer Screening

What we do
  • We research interventions to improve public acceptability and uptake of cancer screening, especially in deprived populations
  • We study ways of optimising the benefits and minimising the human and resource costs of screening programmes
  • We work on development and testing of screening technologies for new programmes
  • We study the progression of cancer to identify optimum times and methods to stop this progression by early detection and prompt treatment
  • We generate evidence on screening intervals, the benefits and harms of screening at different ages, and reasons for differences in screening performance
  • We research risk-based intervals and the potential for personalised screening regimens
  • We study technologies with the potential to improve existing screening programmes
Major Funders
  • Department of Health
  • National Institute of Health Research
  • European Union, Horizon 2020
  • American Cancer Society
Key Publications